We also found that TPX2 promoted the proliferation and migration of lung cancer A549 cells in vitro, suggesting that TPX2 was involved in developing NSCLC and could be a therapeutic target for NSCLC. Here, TPX2 is linked to non-small cell lung carcinoma.